| Boehringer Ingelheim. (12/18/19). "Press Release: Boehringer Ingelheim Discontinues Development of BI 1467335 for NASH". Ingelheim & Sydney. |
2019-12-18 |
| Ferring Pharmaceuticals S.A.. (12/18/19). "Press Release: FerGene Appoints David Meek Chief Executive Officer". Cambridge, MA. |
2019-12-18 |
| Voluntis S.A.. (12/18/19). "Press Release: Voluntis Announces New Pharma Collaboration in Oncology". Cambridge, MA & Paris. |
2019-12-18 |
| Cellestia Biotech AG. (12/17/19). "Press Release: Successful Closing of Series B Financing Round with CHF 20M". Basel. |
2019-12-17 |
| Resistell AG. (12/17/19). "Press Release: Resistell AG Closes CHF 3.5M Series A Financing Round". |
2019-12-17 |
| Roche. (12/17/19). "Press Release: Roche Concludes Acquisition of Spark Therapeutics, Inc. to Strengthen Presence in GeneTherapy". Basel. |
2019-12-17 |
| BioNTech SE. (12/17/19). "Press Release: European Investment Bank Provides Funding of €50 Million to BioNTech as Part of the Investment Plan for Europe". Luxembourg & Mainz. |
2019-12-17 |
| Sidekick Health. (12/16/19). "Press Release: Sidekick Partners with Bayer to Provide Digital Therapy Expansion for PAD Patients". |
2019-12-16 |
| SphingoTec GmbH. (12/16/19). "Press Release: SphingoTec’s Proprietary Biomarker bio-ADM Detects Residual Congestion in Patients with Heart Failure". Hennigsdorf. |
2019-12-16 |
| Federal Trade Commission. (12/16/19). "Press Release: Federal Trade Commission Closes Investigation of Roche Holding AG’s Proposed Acquisition of Spark Therapeutics, Inc.". |
2019-12-16 |
| Innate Pharma S.A.. (12/13/19). "Press Release: Innate Pharma Provides Update on Lacutamab TELLOMAK Trial". Marseille. |
2019-12-13 |
| Boehringer Ingelheim. (12/13/19). "Press Release: Boehringer Ingelheim and Lilly Provide Update on Empagliflozin Phase III Exercise Ability Studies in Chronic Heart Failure". Ingelheim & Indianapolis, IN. |
2019-12-13 |
| Numab Therapeutics AG. (12/12/19). "Press Release: Numab Therapeutics and 3SBio’s Subsidiary Sunshine Guojian Form Partnership to Develop a Portfolio of Novel Multi-specific Antibodies in Immuno-Oncology". Wädenswil, Shengyang & Shanghai. |
2019-12-12 |
| Bioncotech Therapeutics S.L.. (12/12/19). "Press Release: Bioncotech Therapeutics Phase I BO-112 Data Presented at ESMO Immuno-Oncology Congress 2019". Madrid. |
2019-12-12 |
| Creoptix AG. (12/10/19). "Press Release: Creoptix Appoints Line Stigen Raquet as Chief Executive Officer". Wädenswil (Zurich). |
2019-12-10 |
| Owlstone Medical Ltd.. (12/10/19). "Press Release: Owlstone Medical to Join EU-Funded EPHOR Consortium to Advance Occupational Health Science in Order to Reduce Disease Burden from Workplace Exposure". Cambridge. |
2019-12-10 |
| ImmunOs Therapeutics AG. (12/10/19). "Press Release: ImmunOs Therapeutics AG Raises CHF 15M in Series A Financing, Co-led by Pfizer Ventures and BioMedPartners, to Advance a Novel Immunotherapy Agent For Cancer into Human Trials". Schlieren. |
2019-12-10 |
| Stilla Technologies S.A.S.. (12/10/19). "Press Release: Stilla Technologies Names Key Leadership Slate to Support Global Growth of its Next-Generation Digital PCR Solution". Paris. |
2019-12-10 |
| Markes International Ltd.. (12/10/19). "Press Release: Markes Becomes Licensed World Commercial Supplier of Thin-Film Solid-Phase Microextraction (TF-SPME)". |
2019-12-10 |
| TU Braunschweig. (12/10/19). "Pressemitteilung: Start-up zu nachhaltiger Antikörper-Produktion Ausgründung der TU Braunschweig arbeitet an breiter Anwendung". |
2019-12-10 |
| Sanofi S.A.. (12/9/19). "Press Release: Sanofi to Acquire Synthorx to Bolster Its Immuno-oncology Pipeline for $2.5 Billion". Paris & San Diego, CA. |
2019-12-09 |
| Bruker Corporation. (12/9/19). "Press Release: Bruker Introduces Dedicated Light-Sheet Microscope for Highly Multiplexed 3D Cell Culture Live Imaging". Washington, DC. |
2019-12-09 |
| ObsEva S.A.. (12/9/19). "Press Release: ObsEva Announces Positive Results from Uterine Fibroids Phase 3 Study (PRIMROSE 2) of Linzagolix". Geneva & Boston, MA. |
2019-12-09 |
| Algiax Pharmaceuticals. (12/9/19). "Press Release: Algiax Is Ready to Go Into Proof-of-Concept for AP-325 and Welcomes New Investors". Düsseldorf. |
2019-12-09 |
| Eppendorf AG. (12/6/19). "Press Release: Eppendorf with New CEO Dual Leadership. Eva van Pelt and Dr. Peter Fruhstorfer Appointed Co-CEOs – Former CEO, Thomas Bachmann, Left the Company". Hamburg. |
2019-12-06 |
| BC Platforms. (12/6/19). "Press Release: BC Platforms Partners with Leading European Genomics Service Provider Center Life & Brain to Expand Genotyping Services Across Europe". Zürich & Boston, MA. |
2019-12-06 |
| Sartorius AG. (12/5/19). "Press Release: Sartorius Acquires a Majority Stake in Cell Culture Media Specialist Biological Industries". Göttingen. |
2019-12-05 |
| Sartorius AG. (12/5/19). "Press Release: Sartorius Supervisory Board Extends Appointment of Group CEO Joachim Kreuzburg". Göttingen. |
2019-12-05 |
| 4Teen4 Pharmaceuticals GmbH. (12/5/19). "Press Release: Biotech Startup 4Teen4 Pharmaceuticals Closes EUR 7 Million Series A Financing". Hennigsdorf. |
2019-12-05 |
| Ferring Pharmaceuticals S.A.. (12/5/19). "Press Release: FerGene Announces Pivotal Phase 3 Study of Nadofaragene Firadenovec Met Its Primary Endpoint". Washington, DC. |
2019-12-05 |
| ImCheck Therapeutics S.A.S.. (12/4/19). "Press Release: ImCheck Raises $53 Million Series B to Advance Clinical Pipeline of Novel Gamma Delta T-Cell-Focused Antibodies for Cancer and Autoimmune Diseases". Marseille. |
2019-12-04 |
| Mologen AG. (12/3/19). "Press Release: Insolvency Filing [Not for publication or distribution in or into US, AU, CA or JP or any jurisdiction in which unlawful]". Berlin. |
2019-12-03 |
| Kuros Biosciences Ltd.. (12/3/19). "Press Release: Kuros Announces Final Result of Capital Increase – Total Gross Proceeds of CHF 12.5 Million Raised [Not for US, UK, AU, et al.]". Schlieren. |
2019-12-03 |
| Oncopeptides AB. (12/2/19). "Press Release: Oncopeptides Appoints Joseph Horvat as President North America". Stockholm. |
2019-12-02 |
| Indivumed GmbH. (12/2/19). "Press Release: Indivumed Announces Strategic Partnership with Biognosys". Hamburg & Schlieren. |
2019-12-02 |
| Max-Delbrück-Centrum für Molekulare Medizin (MDC). (12/2/19). "Press Release: Deep Learning Identifies Molecular Patterns of Cancer". Berlin. |
2019-12-02 |
| BRAIN AG. (12/2/19). "Press Release: New Chairman of the Management Board – Adriaan Moelker Takes Over from Dr Jürgen Eck". Zwingenberg. |
2019-12-02 |
| CureVac AG. (12/2/19). "Press Release: CureVac Granted Manufacturing Authorization for Its Third GMP Production Suite". Tübingen & Boston, MA. |
2019-12-02 |
| European Invesmtent Bank (EIB). (11/29/19). "Press Release: A European Fund to Support the Circular Bioeconomy". |
2019-11-29 |
| ViGeneron GmbH. (11/28/19). "Press Release: ViGeneron Announces Closing of Series A Financing to Drive Development of Next Generation Gene Therapy Pipeline". Munich. |
2019-11-28 |
| Avantium N.V.. (11/28/19). "Press Release: Avantium Secures Financing Milestone with €25 million EU Funding for FDCA Flagship Plant". Amsterdam. |
2019-11-28 |
| Markes International Ltd.. (11/28/19). "Press Release: New Appointment Signals Asia Pacific Market Growth for Markes International". |
2019-11-28 |
| Qiagen N.V.. (11/27/19). "Press Release: Qiagen and DiaSorin Receive FDA Approval for the Liaison QuantiFERON-TB Gold Plus Test on Liaison Platforms and Begin Commercial Launch". Germantown, MD, Hilden & Saluggia. |
2019-11-27 |
| Helmholtz-Zentrum für Infektionsforschung (HZI. (11/27/19). "Press Release: Helmholtz Gets Three more Start-ups Off the Ground. HZI Spin-off Myxobiotics Researches Active Substance against Urinary Tract Infections". |
2019-11-27 |
| Merck KGaA. (11/26/19). "Press Release: Japan and Singapore Grant CRISPR Patents to Merck". Darmstadt. |
2019-11-26 |
| Novo Holdings A/S. (11/26/19). "Press Release: Novo Seeds Expands Company Formation Activities at BiOrigin with Seasoned Entrepreneurs". Copenhagen. |
2019-11-26 |
| Lonza Group Ltd.. (11/26/19). "Press Release: Lonza and Dinaqor Announce Strategic Collaboration to Advance Gene Therapy Programs for Patients with Monogenic Cardiomyopathies". Basel & Pfäffikon. |
2019-11-26 |
| SHS Gesellschaft für Beteiligungsmanagement mbH. (11/26/19). "Press Release: Establishing a New Standard for the Life Science Industry. SHS Supports Internationalization and Further Growth of Single Use Support". Tübingen & Kufstein. |
2019-11-26 |
| MaxiVax S.A.. (11/26/19). "Press Release: MaxiVax Awarded €2,785,000 European Commission Grant and Announces Successful Closing of Its Series B 2 Round for an Amount of CHF 5 Million". Geneva. |
2019-11-26 |
| Roche. (11/25/19). "Press Release: FDA Grants Priority Review to Roche’s Risdiplam for Spinal Muscular Atrophy". Basel. |
2019-11-25 |
| ChemoCentryx Inc.. (11/25/19). "Press Release: ChemoCentryx and VFMCRP Announce Positive Topline Data from Pivotal Phase III ADVOCATE Trial Demonstrating Avacopan’s Superiority Over Standard of Care in ANCA-Associated Vasculitis". Mountain View, CA & St. |
2019-11-25 |
| GeNeuro S.A.. (11/25/19). "Press Release: GeNeuro and the Karolinska Institutet/Academic Specialist Center of Stockholm Agree to Launch a New Clinical Study of Temelimab in Multiple Sclerosis". Geneva. |
2019-11-25 |
| Ferring Pharmaceuticals S.A.. (11/25/19). "Press Release: Ferring and Blackstone Life Sciences Invest over $570 Million USD in Novel Gene Therapy for Bladder Cancer Patients". Saint-Prex & Cambridge, MA. |
2019-11-25 |
| Alexandria Real Estate Equities, Inc.. (11/25/19). "Press Release: Alexandria Real Estate Equities, Inc. Partners With World-Class Life Science Consortium in Greater Boston". Pasadena, CA. |
2019-11-25 |
| BCNP Consultants GmbH. (11/25/19). "Press Release: World Café »Digitization of the Coating Industry« at the 4th European Chemistry Partnering on February 27, 2020". Frankfurt a. M.. |
2019-11-25 |
| Alkermes plc. (11/25/19). "Press Release: Alkermes Completes Acquisition of Rodin Therapeutics". Dublin. |
2019-11-25 |
| Novartis AG. (11/24/19). "Press Release: Novartis to Acquire The Medicines Company for USD 9.7 bn". Basel. |
2019-11-24 |
| Roche. (11/22/19). "Press Release: Roche Presents Pivotal Data Demonstrating Tecentriq in Combination with Avastin Improves Overall Survival in People with the Most Common Form of Liver Cancer". Basel. |
2019-11-22 |
| Immunitas Therapeutics Inc.. (11/21/19). "Press Release: Immunitas Therapeutics Launches with $39 Million to Advance Lead Programs to Human Efficacy Studies Based on a Unique Immunology-Focused Drug Development Platform". Boston, MA. |
2019-11-21 |
| Merck KGaA. (11/20/19). "Press Release: Merck Announces Orphan Drug Designation for Investigational Therapy Tepotinib in Patients with NSCLC Harboring MET Gene Alterations 8Not intended for UK-based media]". Darmstadt. |
2019-11-20 |
| Qiagen N.V.. (11/20/19). "Press Release: Qiagen and LabCorp Deepen Relationship with Widespread Use of Bioinformatics Solutions". Hilden & Germantown, MD. |
2019-11-20 |
| Coulter Partners. (11/20/19). "Press Release: Coulter Partners Opens Brussels Office and Makes Six Strategic Appointments". |
2019-11-20 |
| CRISPR Therapeutics AG. (11/20/19). "Press Release: CRISPR Therapeutics Announces Pricing of Public Offering of Common Shares". Zug & Cambridge, MA. |
2019-11-20 |
| GHO Capital Partners LLP. (11/20/19). "Press Release: GHO Capital Raises €975m in Largest Ever European Healthcare Fund". London. |
2019-11-20 |
| Sophia Genetics S.A.. (11/20/19). "Press Release: Sophia Genetics Welcomes Milton Silva-Craig to Its Board of Directors". Boston, MA & Lausanne. |
2019-11-20 |
| MorphoSys AG. (11/20/19). "Press Release: Markus Enzelberger, Chief Scientific Officer of MorphoSys, Announces His Departure". Planegg. |
2019-11-20 |
| CRISPR Therapeutics AG. (11/19/19). "Press Release: CRISPR Therapeutics Announces Proposed Public Offering of Common Shares". Zug & Cambridge, MA. |
2019-11-19 |
| CRISPR Therapeutics AG. (11/19/19). "Press Release: CRISPR Therapeutics and Vertex Announce Positive Safety and Efficacy Data From First Two Patients Treated With Investigational CRISPR/Cas9 Gene-Editing Therapy CTX001 for Severe Hemoglobinopathies". Zug |
2019-11-19 |
| Sangamo Therapeutics, Inc.. (11/19/19). "Press Release: Sangamo Announces UK Authorization of a Phase 1/2 Clinical Trial Evaluating the CAR-Treg Cell Therapy TX200 for Kidney Transplantation". Brisbane, CA. |
2019-11-19 |
| Causaly Ltd.. (11/19/19). "Press Release: Causaly Raises $5m in Series A Round Led by Pentech Ventures". London. |
2019-11-19 |
| Rodin Therapeutics Inc.. (11/18/19). "Press Release: Alkermes to Acquire Rodin Therapeutics". Dublin & Boston, MA. |
2019-11-18 |
| Rentschler Biopharma SE. (11/18/19). "Press Release: Rentschler Biopharma Appoints New Executives to Join U.S. Team". Laupheim & Milford, MA. |
2019-11-18 |
| Qiagen N.V.. (11/15/19). "Press Release: Qiagen Receives Several Conditional, Non-binding Indications of Interest, Enters into Discussions to Explore Potential Strategic Alternatives". Venlo. |
2019-11-15 |
| MorphoSys AG. (11/15/19). "Press Release: MorphoSys Continues to Build Commercial Presence by Opening New U.S. Headoffice". Planegg & Boston, MA. |
2019-11-15 |
| Turbine Kft.. (11/13/19). "Press Release: Turbine Secures €3 Million Seed Fund to Expand the Potential of Simulation-first Drug discovery". London & Budapest. |
2019-11-13 |
| Lonza Group Ltd.. (11/12/19). "Press Release: Board Announcement". Basel. |
2019-11-12 |
| ProBioGen AG. (11/12/19). "Press Release: DirectedLuck, a Transposase for Efficient Gene Delivery and High-Titer Cell Line Development". Berlin. |
2019-11-12 |
| Merck KGaA. (11/12/19). "Press Release: Merck Licenses CRISPR Gene-Editing Technology to Evotec". Darmstadt. |
2019-11-12 |
| 4SC AG. (11/12/19). "Press Release: 4SC AG Secures circa EUR 22.4 Million from a Capital Increase [Not for release in US, Australia, Canada, et al.]". Planegg-Martinsried. |
2019-11-12 |
| Vaximm AG. (11/12/19). "Press Release: NEC and Vaximm Announce Collaboration to Advance Personalized Neoantigen Cancer Vaccines". Tokyo, Basel & Mannheim. |
2019-11-12 |
| Genedata AG. (11/12/19). "Press Release: Immatics Implements Genedata Biologics into Proprietary T-Cell Receptor Discovery and Engineering XCEPTOR Platform". Basel. |
2019-11-12 |
| Flagship Pioneering. (11/12/19). "Press Release: Flagship Pioneering Appoints Prakash Raman, Ph.D. as Senior Partner and Chief Business Development Officer". Cambridge, MA. |
2019-11-12 |
| [iito] Business Intelligence. (11/11/19). "Press Release: [iito] Launches Transatlantic Life Sciences Business Portal at BIO-Europe". Bremen & Hamburg. |
2019-11-11 |
| Expedeon AG. (11/11/19). "Press Release: Expedeon AG Signs EUR 120 Million Deal with Abcam for the Sale of Its immunology and Proteomics Business". Heidelberg & Cambridge. |
2019-11-11 |
| Numares AG. (11/8/19). "Press Release: University Hospital Regensburg and Numares Present Results for Detection of Acute Kidney Transplant Rejection Based on a Simple Urine Test". Regensburg. |
2019-11-08 |
| BC Platforms. (11/7/19). "Press Release: BC Platforms Opens New Entity in Singapore to Spearhead its Asia Pacific Strategy and Hosts Launch Event in Precision Medicine". Zürich & Boston, MA. |
2019-11-07 |
| eGenesis Inc.. (11/7/19). "Press Release: eGenesis Announces $100 Million Series B Financing". Cambridge, MA. |
2019-11-07 |
| Owlstone Medical Ltd.. (11/7/19). "Press Release: Owlstone Medical Enters Partnership with Thermo Fisher Scientific to Advance Early Disease Detection Using Non-invasive Breath Biopsy". Cambridge. |
2019-11-07 |
| Centogene B.V.. (11/7/19). "Press Release: Centogene Announces Pricing of Initial Public Offering". Cambridge, MA & Rostock. |
2019-11-07 |
| Evotec SE. (11/6/19). "Press Release: Evotec and Vifor Pharma Form Joint Venture for Early Development in Nephrology". Hamburg & St. Gallen. |
2019-11-06 |
| Rentschler Biopharma SE. (11/6/19). "Press Release: Rentschler Biopharma Kicks off Expansion at U.S. Facility in the Boston Biotech Hub". Laupheim & Milford, MA. |
2019-11-06 |
| ADC Therapeutics S.A.. (11/5/19). "Press Release: ADC Therapeutics Appoints Jennifer Herron as Chief Commercial Officer". Lausanne. |
2019-11-05 |
| SciRhom GmbH. (11/5/19). "Press Release: SciRhom Initiates First-In-Class Antibody Development Program to Treat Major Autoimmune Diseases". Munich. |
2019-11-05 |
| TRG Management LLP. (11/5/19). "Press Release: The Rohatyn Group Completes Its Investment in Amethyst Radiotherapy, A Leading Operator of Oncology Radiotherapy Clinics Across Europe". New York, NY. |
2019-11-05 |
| Boehringer Ingelheim. (11/4/19). "Press Release: Boehringer Ingelheim and Lilly Modernise Alliance to Focus Full Expertise on Jardiance". Ingelheim & Indianapolis, IN. |
2019-11-04 |
| Santhera Pharmaceuticals AG. (11/4/19). "Press Release: Santhera Appoints New Chief Executive Officer". Pratteln. |
2019-11-04 |
| Pieris Pharmaceuticals, Inc.. (11/4/19). "Press Release: Pieris Pharmaceuticals Announces $32 Million Private Placement and Potential Funding Mechanism for PRS-060 Co-development Opt-in". Boston, MA. |
2019-11-04 |
| Xlife Sciences AG. (11/4/19). "Press Release: Xlife Siences AG. New Project in the Portfolio". Zurich. |
2019-11-04 |
| Roivant Sciences GmbH. (10/31/19). "Press Release: Sumitomo Dainippon Pharma and Roivant Sciences Sign Definitive Agreement for Strategic Alliance". Tokyo, Osaka, London & Basel. |
2019-10-31 |
| genOway S.A.. (10/30/19). "Press Release: The Institut Pasteur and Cellectis Extend Exclusive License Rights by Granting genOway the Authority to Take Action against Infringement". Lyon & Paris. |
2019-10-30 |
![[LSG] Life-Sciences-Germany.com - The Life Sciences Web Portal for German-speaking Europe](/images/basics/lsg-life-sciences-germany-portal-logo-2019.png){kind=logo}
1 2 3 ... 9 10 11 ... 44 45 46 
Date
![Picture [iito] Made Without Love 650x80px](/banner/iito-business-intelligence-20200507-650-080-summer-banner-series-made-without-love.jpg)
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20111029-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
